Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in  ≥ 50-year-old adults

When two or more vaccines are administered concurrently, there is concern about safety and immunogenicity from vaccine interaction.
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Tags: Research article Source Type: research